Free Newsletter
Catalyst offers more efficient drug production method
A team of professors at the Boston College Chemistry Department have developed a small molecule catalyst they say can significantly streamline the production of therapeutics and chemicals. The essence of their work focused on the mirror-image molecules that are present in chemical compounds. One of those two hands, or enantiomers, can be harmful. The team--led by Amir Hoveyda and Marc Snapper--developed a "silylation catalyst" so that only one hand is formed, reducing the number of steps in the process from five to one.
"This is an elegant solution to a very important, practical problem, with the potential to result in more efficient, more environmentally friendly, and less expensive processes for manufacturing drugs," said John M. Schwab, a chemist at the National Institute of General Medical Science, which supported the work.
- read this report on the catalyst from the Royal Society of Chemistry
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact




